TNF Pharmaceuticals Inc: A Glimpse into the Company’s Current Standing

TNF Pharmaceuticals Inc, a company operating within the Health Care sector, specifically in the Health Care Equipment & Supplies industry, has been making headlines recently. As of July 24, 2025, the company’s stock closed at $0.117 on the Nasdaq exchange. This figure is notably low compared to the 52-week high of $2.16, recorded on August 21, 2024. The recent dip in stock price is further emphasized by the 52-week low of $0.085, observed on July 17, 2025.

The company’s market capitalization stands at $1,870,000 USD, reflecting its current valuation in the market. However, the financial metrics reveal some challenges, with a Price Earnings (P/E) ratio of -0.288903, indicating that the company is not currently generating profits.

TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company that focuses on developing innovative drug products aimed at addressing aging and age-related diseases, chronic pain, anxiety, and sleep disorders. As a global entity, the company serves a diverse customer base worldwide, offering a wide range of health care equipment and supplies.

For those interested in learning more about TNF Pharmaceuticals Inc’s mission and product offerings, further information is available on their website. Additionally, investors looking to engage with the company’s ventures can do so through trading on the Nasdaq stock exchange.

Despite the current financial challenges, TNF Pharmaceuticals Inc continues to be a significant player in the health care sector, with a focus on revolutionizing treatment options for various health conditions.